| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |